Assessment of Minimal/Measurable Residual Disease Testing in Acute Myeloid Leukaemia By Molecular Methods in an Interlaboratory Study
- Resource Type
- Abstract
- Source
- In
Blood 23 November 2021 138 Supplement 1:3461-3461 - Subject
- Language
- ISSN
- 0006-4971